AN2 Therapeutics Inc (ANTX)vsModerna Inc (MRNA)
ANTX
AN2 Therapeutics Inc
$4.89
+1.24%
HEALTHCARE · Cap: $182.27M
MRNA
Moderna Inc
$194.82
+6.98%
HEALTHCARE · Cap: $69.04B
Smart Verdict
WallStSmart Research — data-driven comparison
ANTX leads profitability with a 0.0% profit margin vs -141.4%. ANTX earns a higher WallStSmart Score of 27/100 (F).
ANTX
Avoid27
out of 100
Grade: F
MRNA
Avoid21
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for ANTX.
Margin of Safety
+69.9%
Fair Value
$134.69
Current Price
$194.82
$60.13 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Large-cap with strong market position
Conservative balance sheet, low leverage
Areas to Watch
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Trading at 11.5x book value
2.1% revenue growth
Weak financial health signals
ROE of -46.6% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : ANTX
The strongest argument for ANTX centers on Price/Book.
Bull Case : MRNA
The strongest argument for MRNA centers on Market Cap, Debt/Equity.
Bear Case : ANTX
The primary concerns for ANTX are Revenue Growth, EPS Growth, Market Cap.
Bear Case : MRNA
The primary concerns for MRNA are Price/Book, Revenue Growth, Piotroski F-Score.
Key Dynamics to Monitor
ANTX profiles as a value stock while MRNA is a turnaround play — different risk/reward profiles.
MRNA carries more volatility with a beta of 1.11 — expect wider price swings.
MRNA is growing revenue faster at 2.1% — sustainability is the question.
ANTX generates stronger free cash flow (-7M), providing more financial flexibility.
Bottom Line
ANTX scores higher overall (27/100 vs 21/100). MRNA offers better value entry with a 69.9% margin of safety. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
AN2 Therapeutics Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Anthem, Inc., is a health benefits company in the United States. The company is headquartered in Indianapolis, Indiana.
Moderna Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?